<?xml version="1.0" encoding="UTF-8"?><BillSummaries>
<item congress="115" measure-type="hr" measure-number="5582" measure-id="id115hr5582" originChamber="HOUSE" orig-publish-date="2018-04-23" update-date="2018-07-19">
<title>Abuse Deterrent Access Act of 2018</title>
<summary summary-id="id115hr5582v36" currentChamber="HOUSE" update-date="2018-07-19">
<action-date>2018-06-12</action-date>
<action-desc>Passed House amended</action-desc>
<summary-text><![CDATA[<p><b>Abuse Deterrent Access Act of 2018</b><br /> </p> <p>(Sec. 2) This bill requires the Centers for Medicare &amp; Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in&nbsp;a&nbsp;prescription drug plan under Medicare or Medicare Advantage (MA). The report&nbsp;must account for&nbsp;any barriers preventing enrollees from accessing such formulations under Medicare or MA. </p>]]></summary-text>
</summary>
<summary summary-id="id115hr5582v17" currentChamber="HOUSE" update-date="2018-06-12">
<action-date>2018-06-08</action-date>
<action-desc>Reported to House with amendment(s)</action-desc>
<summary-text><![CDATA[<p><b>Abuse Deterrent Access Act of 2018</b><br /> </p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in&nbsp;a&nbsp;prescription drug plan under Medicare or Medicare Advantage (MA). The report&nbsp;must account for&nbsp;any barriers preventing enrollees from accessing such formulations under Medicare or MA. </p>]]></summary-text>
</summary>
<summary summary-id="id115hr5582v00" currentChamber="HOUSE" update-date="2018-05-02">
<action-date>2018-04-23</action-date>
<action-desc>Introduced in House</action-desc>
<summary-text><![CDATA[<p><b>Abuse Deterrent Access Act of 2018</b><br /></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in&nbsp;a&nbsp;prescription drug plan under Medicare or Medicare Advantage (MA). The report&nbsp;must account for&nbsp;any barriers preventing enrollees from accessing such formulations under Medicare or MA. </p>]]></summary-text>
</summary>
</item>
<dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
<dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
<dc:description>This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
</dublinCore>
</BillSummaries>
